Zealand Pharma has announced the appointment of Frank Sanders as President of Zealand Pharma U.S.
Frank Sanders will join Zealand on July 6, 2020.
“I am pleased to welcome Frank Sanders to Zealand Pharma, and am confident that he will provide strong and experienced leadership for our U.S. organization,” said Emmanuel Dulac, President and Chief Executive Officer at Zealand Pharma. “Frank has more than 25 years of experience within commercial operations. He is well equipped to lead Zealand’s commercial operations to focus on growing existing sales of V-Go and to successfully launch four potential products beginning in 2021.”
Both start-up and established companies
Frank has extensive experience in leading multidisciplinary operational teams to achieve successfully their growth strategies, states the company. He joins Zealand at a critical point in the company’s journey toward commercializing its products. Frank has worked in both start-up and established companies, where he has built, led and scaled organizations across sales, account management, marketing, pricing and contract strategy, operations, and patient support.
Prior to joining Zealand Pharma, Frank served as the general manager of the U.S. Commercial team at Sage Therapeutics. Earlier experience was gained through roles of increasing commercial responsibilities at Janssen and GlaxoSmithKline. Frank holds a Bachelor’s in Business Administration from Wittenberg University (Ohio, U.S.).
“This is an exciting opportunity to join Zealand Pharma, and to be a part of the company’s transformative journey,” commented Frank Sanders. “I have been impressed by the team through our interactions so far, and I further appreciate the insights I gained to the potential of the business. I look forward to working with the extended team that is preparing to deliver Zealand products and create positive impact in the lives of patients, their families and caregivers.”
Leading the U.S. organization from Zealand’s Boston-area office, Frank will be a member of the international corporate management team reporting to President and Chief Executive Officer Emmanuel Dulac.
Photo: Zealand Pharma